Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
somatropin + platelet-rich plasma
- Development stage
- Unknown
- Lead developer
- Integrant
- Modality
- Recombinant Proteins and Enzymes, Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
- Administration
- Intraarticular
01
Overview
A combination therapy consisting of **somatropin** (recombinant human growth hormone) and **platelet-rich plasma (PRP)**, administered primarily via intra-articular injection. Somatropin acts as a systemic growth factor by stimulating growth, cell reproduction, and regeneration, while PRP is an autologous blood-derived product enriched in platelets and a broad array of naturally occurring growth factors, chemokines, and cytokines that locally stimulate tissue regeneration and healing. This combination has been evaluated for regenerative and anti-inflammatory effects, aiming to synergistically enhance tissue repair in musculoskeletal conditions—most notably for osteoarthritis of the knee and other joints—by combining systemic and local trophic effects[2][3][5].
- Other names
- Intra-articular Growth Hormone and Platelet-Rich PlasmaIA HGH + PRPHGH + PRPGrowth hormone + Platelet-rich plasma
02
Targets
PDGFR (PDGFR family)IGF-1R (Insulin-like growth factor 1 receptor)FGFR (FGFR family)GHR (Growth hormone receptor)VEGFR (VEGFR family)
Beyond the preview
Go deeper on somatropin + platelet-rich plasma.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on somatropin + platelet-rich plasma.